Sleep disorders in multiple sclerosis

Handbook of Clinical Neurology

Volumn 99, Issue C, 2011, Pages 1139-1146

  Ferini Strambi, Luigi ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149386268     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52007-4.00025-4     Document Type: Book

References (80)

1. Achiron A., Barak Y., Gabbay U. Sleep disturbance in multiple sclerosis: clinical and neuroradiologic correlations related to disease activity. J Neuroimmunol 1995, 56-63(Suppl 1):57.
2. Amarenco G., Kerdraon J., Denys P. [Bladder and sphincter disorders in multiple sclerosis. Clinical, urodynamic and neurophysiological study of 225 cases.]. Rev Neurol (Paris) 1995, 151:722-730.
3. Antonijevic I.A., Steiger A. Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis. Psychoneuroendocrinology 2003, 28:780-795.
4. Attarian H. Importance of sleep in the quality of life of multiple sclerosis patients: a long under-recognized issue. Sleep Med 2009, 10:7-8.
5. Auer R.N., Rowlands C.G., Perry S.F., et al. Multiple sclerosis with medullary plaques and fatal sleep apnea (Ondine's curse). Clin Neuropathol 1996, 15:101-105.
6. Auger M.S., Montplaisir J., Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology 2005, 65:1652-1653.
7. Bara-Jimenez W., Aksu M., Graham B., et al. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000, 54:1609-1616.
8. Bonduelle M., Degos C. Symptomatic narcolepsies: a critical study. Narcolepsy 1976, 322-325. Spectrum, New York. C. Guilleminault, W.C. Dement, P. Passouant (Eds.).
9. Born J., Zwick A., Roth G., et al. Differential effects of hydrocortisone, fluocortolone, and aldosterone on nocturnal sleep in humans. Acta Endocrinol 1987, 116:129-137.
10. Breslau N., Roth T., Rosenthal L., et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiologic study of young adults. Biol Psychiatry 1996, 39:411-418.
11. Chrousos G.A., Kattah J.C., Beck R.W., et al. Side effects of glucocorticoid treatment. Experience of the optic neuritis treatment trial. JAMA 1993, 269:2110-2112.
12. Coleman R.M., Bliwise D.L., Sajben N., et al. Epidemiology of periodic limb movements during sleep. Sleep/Wake Disorders: Natural History, Epidemiology and Long Term Evolution 1988, 217-229. Raven Press, New York. C. Guilleminault, E. Lugaresi (Eds.).
13. de Mello M.T., Poyares D.L., Tufik S. Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions. Spinal Cord 1999, 37:634-637.
14. Deriu M., Cossu G., Molari A., et al. Restless legs syndrome in multiple sclerosis: a case-control study. Mov Disord 2009, 5:697-701.
15. Despault-Duquette P.O., Emond F., Duquette P. Restless legs syndrome in multiple sclerosis. Ann Neurol 2002, 52(Suppl 1):S42.
16. Douay X., Waucquier N., Hautecoeur P., et al. High prevalence of restless legs syndrome in multiple sclerosis. Rev Neurol 2009, 165:194-196.
17. Duquette P., Decary F., Pleines J., et al. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci 1985, 12:106-110.
18. Feinstein A., Kartsounis L.D., Miller D.H., et al. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry 1992, 55:869-876.
19. Ferini-Strambi L., Filippi M., Martinelli V., et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 1994, 125:194-197.
20. Ferini-Strambi L., Fantini M.L., Zucconi M., et al. REM sleep behavior disorder. Neurol Sci 2005, 26(Suppl 3):186-192.
21. Figved N., Klevan G., Myhr K.M., et al. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatr Scand 2005, 112:463-468.
22. Fleming W.E., Pollack C.P. Sleep disorders in multiple sclerosis. Semin Neurol 2005, 25:64-68.
23. Fox E.J. Management of worsening multiple sclerosis with mitoxantrone: a review. Clin Ther 2006, 28:461-474.
24. Fruehwald S., Loeffler-Stastka H., Eher R., et al. Depression and quality of life in multiple sclerosis. Acta Neurol Scand 2001, 104:257-261.
25. Goeb J.L., Even C., Nicolas G., et al. Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry 2006, 21:186-193.
26. Gomez-Choco M.J., Iranzo A., Blanco Y., et al. Prevalence of restless legs syndrome and REM sleep behaviour disorder in multiple sclerosis. Mult Scler 2007, 13:805-808.
27. Guillain G., Alajouanine T. La somnolence dans la sclérose en plaques. Les episodes aigus ou subaigus de la sclérose en laques pouvant simuler l'encephalite lethargique. Ann Med 1928, 24:111-118.
28. Guilleminault C., Fromherz S. Narcolepsy: diagnosis and treatment. Principles and Practice of Sleep Medicine 2005, 781-790. Elsevier Saunders, Philadelphia. 4th edn. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
29. Haas J., Maas-Enriquez M., Hartung H.P. Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis: results of a retrospective multicenter observational study over 5 years. Mult Scler 2005, 11:562-567.
30. Hartmann M., Pfister R., Pfadenhauer K. Restless legs syndrome associated with spinal cord lesions. J Neurol Neurosurg Psychiatry 1999, 66:688-689.
31. Howard R.S., Wiles C.M., Hirsch N.P., et al. Respiratory involvement in multiple sclerosis. Brain 1992, 115:479-494.
32. Huber S., Spycher M., Lechner-Scott J., et al. [Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland.]. Schweiz Med Wochenschr 1996, 126:1475-1481.
33. Iseki K., Mezaki T., Oka Y., et al. Hypersomnia in MS. Neurology 2002, 59:2006-2007.
34. Jacobson E. Fall von narcolepsie. Klin Wochenschr 1926, 2:2188.
35. Kalia L.V., O'Connor P.W. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler 2005, 11:322-327.
36. Kalsi V., Fowler C.J. Therapy insight: bladder dysfunction associated with multiple sclerosis. Nat Clin Pract Urol 2005, 2:492-501.
37. Kato T., Kanbayashi T., Yamamoto K., et al. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med 2003, 42:743-745.
38. Lee J.S., Lee P.H., Huh K. Periodic limb movements in sleep after a small deep subcortical infarct. Mov Disord 2005, 20:260-261.
39. Leo G.J., Rao S.M., Bernardin L. Sleep disturbance in multiple sclerosis. Neurology 1991, 41(Suppl 1):320. (abstract).
40. Leriche L., Schwartz J.C., Sokoloff P. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Neuropharmacology 2003, 45:174-181.
41. Mahowald M.W., Schenck C.H. REM sleep behavior disorder - past , present and future. Schweiz Arch Neurol Psychiatr 2003, 154:363-368.
42. Mahowald M.W., Schenck C.H. REM sleep parasomnias. Principles and Practice of Sleep Medicine 2005, 897-916. Elsevier Saunders, Philadelphia. 4th edn. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
43. Manconi M., Fabbrini M., Bonanni E., et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol 2007, 14:534-539.
44. Manconi M., Ferini-Strambi L., Filippi M., et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis. The REMS Study. Sleep 2008, 31:944-952.
45. Manconi M., Rocca M., Ferini-Strambi L., et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler 2008, 14:86-93.
46. McGuigan C., Hutchinson M. Unrecognised symptoms of depression in a community-based population with multiple sclerosis. J Neurol 2006, 253:219-223.
47. Mignot E. Narcolepsy: pharmacology, pathophysiology and genetics. Principles and Practice of Sleep Medicine 2005, 761-779. Elsevier Saunders, Philadelphia. 4th edn. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
48. Mohr D.C., Hart S.L., Fonareva I., et al. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler 2006, 12:204-208.
49. Montplaisir J., Allen R., Walters S.A., et al. Restless legs syndrome and periodic limb movements during sleep. Principles and Practice of Sleep Medicine 2005, 839-852. Elsevier-Saunders, Philadelphia. 4th edn. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
50. Moreira N.C.V., Damasceno R.S., Medeiros C.A., et al. Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients. Braz J Med Biol Res 2008, 41:902-907.
51. Nofzinger E.A., Reynolds C.F. REM sleep behavior disorder. JAMA 1994, 271:820.
52. Nuotio M., Tammela T.L., Luukkaala T., et al. Predictors of institutionalization in an older population during a 13-year period: the effect of urge incontinence. J Gerontol A Biol Sci Med Sci 2003, 58:756-762.
53. Ohayon M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002, 6:97-111.
54. Ondo W.G., He Y., Rajasekaran S., et al. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2000, 15:154-158.
55. Onen S.H., Alloui A., Gross A., et al. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 2001, 10:35-42.
56. Osterberg A., Boivie J., Thuomas K.A. Central pain in multiple sclerosis: prevalence and clinical characteristics. Eur J Pain 2005, 9:531-542.
57. Patel S.R., Malhotra A., Gottlieb D.J., et al. Correlates of long sleep duration. Sleep 2006, 29:881-889.
58. Picchietti D., Winkelman J.W. Restless legs syndrome, periodic limb movements in sleep and depression. Sleep 2005, 28:891-898.
59. Plazzi G., Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med 2002, 3:437-439.
60. Provini F., Vetrugno R., Meletti S., et al. Motor pattern of periodic limb movements during sleep. Neurology 2001, 57:300-304.
61. Rae-Grant A.D., Eckert N.J., Bartz S., et al. Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity. Mult Scler 1999, 5:179-183.
62. Rammohan K.W., Rosenberg J.H., Lynn D.J., et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002, 72:179-183.
63. Rog D.J., Nurmikko T.J., Friede T., et al. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005, 65:812-819.
64. Sadovnick A.D., Remick R.A., Allen J., et al. Depression and multiple sclerosis. Neurology 1996, 46:628-632.
65. Saunders J., Whitham R., Schaumann B. Sleep disturbance, fatigue, and depression in multiple sclerosis. Neurology 1991, 41(Suppl 1):320.
66. Scammell T.E., Estabrooke I.V., McCarthy M.T., et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000, 20:8620-8628.
67. Schattschneider J., Bode A., Wasner G., et al. Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. J Neurol 2004, 251:977-982.
68. Schrader H., Gotlibsen O.B., Skomedal G.N. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980, 30:105-108.
69. Schulte-Baukloh H., Schobert J., Stolze T., et al. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis. Neurourol Urodyn 2006, 25:110-115.
70. Solaro C., Uccelli M.M., Guglieri P., et al. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Mult Scler 2000, 6:192-193.
71. Stankoff B., Waubant E., Confavreux C., et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 2005, 64:1139-1143.
72. Tachibana N., Howard R.S., Hirsch N.P., et al. Sleep problems in multiple sclerosis. Eur Neurol 1994, 34:320-323.
73. Tippmann-Peikert M., Boeve B.F., Keegan B.M. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology 2006, 66:1277-1279.
74. Valiquette G., Herbert J., Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol 1996, 53:1270-1275.
75. Vallittu A.M., Peltoniemi J., Elovara I., et al. The efficacy of glatiramer acetate in beta-interferon-intolerant MS patients. Acta Neurol Scand 2005, 112:234-237.
76. Vetrugno R., Stecchi S., Scandellari C., et al. Sleep-wake and body core temperature rhythms in multiple sclerosis with fatigue. Clin Neurophysiol 2007, 118:228-234.
77. Winkelman J.W., James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004, 27:317-321.
78. Winkelmann J., Wetter T.C., Trenkwalder C., et al. Periodic limb movements in syringomyelia and syringobulbia. Mov Disord 2000, 15:752-753.
79. Wunderlin B.W., Kesselring J., Ginzler H., et al. Fatigue in multiple sclerosis is not due to sleep apnea. Eur J Neurol 1997, 4:72-78.
80. Yokota T., Hirose K., Tanabe H., et al. Sleep-related periodic leg movements (nocturnal myoclonus) due to spinal cord lesion. J Neurol Sci 1991, 104:13-18.